This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


COVID-19 vaccine introduction: Insights from malaria, meningitis, and more

December 3, 2020 by PATH

As COVID-19 vaccines become available, the world must have the infrastructure, supply chains, and distributions plans in place to introduce the vaccines at unprecedented scale and speed. What have we learned from past vaccine implementations that can guide an effective, equitable rollout strategy? Join our panel to examine lessons learned from years of experience introducing vaccines for malaria, meningitis, and more, and to discuss how these insights can inform efficient introduction plans for COVID-19 vaccines.

Dr. Deborah Atherly
, Global Head, Policy, Access, and Introduction, Center for Vaccine Innovation and Access, PATH (Moderator)
Dr. Phionah Atuhebwe, Regional New Vaccines Introduction Medical Officer, WHO Regional Office for Africa
Dr. Rose Jalang’o, Strategic Information Management and Communications officer, National Vaccines and Immunization Program, Ministry of Health, Kenya
John Bawa, Africa Lead, Vaccine Implementation, PATH

This PATH Live Forum is made possible by the ExxonMobil Foundation.

Join the conversation

View all past and upcoming PATH Live Forums

PATH Live Forums are curated live conversations with experts from PATH and our partners, with plenty of time for your questions.

Explore the Forums